Free Republic
Browse · Search
General/Chat
Topics · Post Article

Skip to comments.

Global study could change how children with multiple sclerosis are treated (Treat with adult therapies)
Medical Xpress / Melbourne Health / The Lancet Child & Adolescent Health ^ | March 25, 2024 | Dr. Sifat Sharmin et al

Posted on 03/29/2024 8:00:07 PM PDT by ConservativeMind

A new study—the largest of its kind globally—has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-efficacy therapies as adults.

There are a limited number of therapies approved for children with MS, with only one considered to be of high efficacy—meaning highly effective.

However, a Royal Melbourne Hospital (RMH) observational study has determined that pediatric patients should be treated with the same high-efficacy treatments offered to adults as early in their diagnosis as possible to avoid the onset of significant disability.

"We found that patients who were treated with high-efficacy disease-modifying therapies during the initial phases of their disease benefited the most compared to patients who were not treated," Dr. Sifat Sharmin said.

"Based on our findings we recommend that patients with pediatric-onset multiple sclerosis should be treated early in the disease course, when the disability is still minimal, to preserve neurological capacity before it's damaged."

The observational study analyzed global data of more than 5,000 people diagnosed with MS during childhood over the last 30 years—including from MSBase, a large international registry encompassing 41 countries, and a national registry in Italy.

It compared the strength of treatment with the severity of the disease later in life, and concluded patients treated with the most effective treatments early on in their diagnosis were less likely to experience disability worsening. These disease-modifying therapies include highly effective antibodies that change the way in which an individual's immune system behaves.

The research also confirmed that any treatment—including low-efficacy treatments—was better than no treatment

Dr. Sharmin, who led the study, said because pediatric-onset MS was a rare disease—about 4–8% of MS patients are diagnosed before age 18—it wasn't as well investigated.

"This is the largest study of its kind for pediatric MS," she said.

(Excerpt) Read more at medicalxpress.com ...


TOPICS: Health/Medicine
KEYWORDS: ms
Give the kids the best of what adults get, and they appear to be able to handle it, well.
1 posted on 03/29/2024 8:00:07 PM PDT by ConservativeMind
[ Post Reply | Private Reply | View Replies]

To: Mazey; ckilmer; goodnesswins; Jane Long; BusterDog; jy8z; ProtectOurFreedom; matthew fuller; ...

The “Take Charge Of Your Health” Ping List

This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

2 posted on 03/29/2024 8:01:37 PM PDT by ConservativeMind (Trump: Befuddling Democrats, Republicans, and the Media for the benefit of the US and all mankind.)
[ Post Reply | Private Reply | To 1 | View Replies]

To: ConservativeMind

Studies show that the Keto Diet is good for managing MS in adults.

It remains to be seen, however if Keto is recommended for children.


3 posted on 03/29/2024 8:06:05 PM PDT by dfwgator (Endut! Hoch Hech!)
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
General/Chat
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson